Precision Medical is proud to announce its strategic partnership with NSW Health, enabling public hospitals across New South Wales to access our MaQS Tracking Software through the Standing Offer Arrangement under STE 953.
This significant collaboration represents a major step forward in supporting the delivery of efficient, data-driven healthcare services across the state. Under the Standing Offer Arrangement (SOA) STE 953, NSW Health facilities can now seamlessly procure and implement Precision Medical’s MaQS (Management and Quality System) Tracking Software, a robust digital solution designed specifically for healthcare environments.
The MaQS Tracking Software provides a comprehensive platform for real-time tracking, management, and optimisation of medical equipment and consumables. Key features include:
- Real-time location tracking of critical medical assets using RFID and barcode technologies.
- Automated inventory management that reduces manual handling, minimizes loss, and ensures optimal stock levels.
- Maintenance scheduling and compliance monitoring, helping hospitals meet regulatory standards and extend equipment lifespan.
- Detailed usage analytics and reporting, empowering hospital administrators to make informed decisions on asset utilization, budgeting, and procurement.
- Integration capabilities with existing hospital systems, including Electronic Medical Records (EMR), asset management, and supply chain platforms.
By leveraging MaQS, NSW hospitals are positioned to enhance operational efficiency, reduce waste, increase accountability, and ultimately improve patient care outcomes. Precision Medical is committed to supporting healthcare providers with tools that not only increase transparency and traceability but also contribute to safer, more sustainable healthcare practices.
This partnership with NSW Health reflects our ongoing dedication to innovation and excellence in healthcare technology, and we are honoured to play a role in strengthening public health infrastructure throughout New South Wales.